Mid Atlantic Financial Management’s iShares MBS ETF MBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$6.33M Sell
58,561
-500
-0.8% -$54.2K 0.42% 43
2021
Q2
$6.39M Buy
59,061
+3,455
+6% +$375K 0.43% 43
2021
Q1
$6.03M Buy
55,606
+11,352
+26% +$1.24M 0.44% 47
2020
Q4
$4.87M Buy
44,254
+402
+0.9% +$44.3K 0.37% 63
2020
Q3
$4.82M Buy
43,852
+15,208
+53% +$1.68M 0.42% 50
2020
Q2
$3.17M Sell
28,644
-7,110
-20% -$787K 0.31% 75
2020
Q1
$3.95M Buy
35,754
+350
+1% +$38.1K 0.45% 45
2019
Q4
$3.83M Buy
35,404
+8,202
+30% +$886K 0.36% 68
2019
Q3
$2.95M Buy
27,202
+12,683
+87% +$1.37M 0.31% 64
2019
Q2
$1.56M Buy
14,519
+612
+4% +$65.1K 0.16% 124
2019
Q1
$1.48M Sell
13,907
-89
-0.6% -$9.36K 0.16% 118
2018
Q4
$1.47M Buy
+13,996
New +$1.44M 0.18% 120

Other funds holding MBB

Mid Atlantic Financial Management's MBB Position: Q3 2021 in Review

Mid Atlantic Financial Management reduced its iShares MBS ETF (MBB) stake by 0.85% in Q3 2021, selling an estimated $54.2K and leaving 58,561 shares worth $6.33M. The position accounts for 0.42% of the portfolio, ranked #43.

Mid Atlantic Financial Management first reported a position in MBB in Q4 2018 and has held it in 12 quarters since. The position peaked at $6.39M in Q2 2021. 681 funds tracked by Wall St. Rank hold MBB as of Q3 2021.

  • Mid Atlantic Financial Management held 58,561 shares of iShares MBS ETF worth $6.33M as of Q3 2021.
  • Mid Atlantic Financial Management sold 500 iShares MBS ETF shares in Q3 2021, an estimated $54.2K.
  • iShares MBS ETF made up 0.42% of Mid Atlantic Financial Management's portfolio in Q3 2021, its #43 holding.
  • Mid Atlantic Financial Management first reported a position in iShares MBS ETF in Q4 2018 and has held it in 12 quarters since.
  • Mid Atlantic Financial Management's iShares MBS ETF position peaked at $6.39M in Q2 2021.
  • 681 funds tracked by Wall St. Rank held iShares MBS ETF as of Q3 2021.

Based on Mid Atlantic Financial Management's 13F filing for Q3 2021, filed 12 Nov 2021.